China SXT Pharmaceuticals Inc (SXTC) — Cash Flow Quality Index
China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Quality Index of -13.83x as of June 2026. Operating cash flow of $-2.26 Million is below net income of $163.72K, suggesting accrual-heavy earnings not yet converted to cash. Explore China SXT Pharmaceuticals Inc (SXTC) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China SXT Pharmaceuticals Inc Cash Flow Quality Index (2016–2019)
Historical Cash Flow Quality Index for China SXT Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check China SXT Pharmaceuticals Inc (SXTC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for China SXT Pharmaceuticals Inc (2016–2019)
Year-by-year earnings quality comparison for China SXT Pharmaceuticals Inc. For live market cap and the full company financial profile, see China SXT Pharmaceuticals Inc (SXTC) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.16x | $239.19K | $1.54 Million | ▼ -90.4% |
| 2018 | 1.62x | $1.92 Million | $1.19 Million | ▲ +553.9% |
| 2017 | 0.25x | $293.04K | $1.19 Million | ▼ -80.8% |
| 2016 | 1.29x | $182.47K | $141.54K | — |